206 related articles for article (PubMed ID: 27135371)
21. Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B.
Oh JM; Jang HJ; Kim WJ; Kang MG; Baek SC; Lee JP; Park D; Oh SR; Kim H
Int J Biol Macromol; 2020 May; 151():441-448. PubMed ID: 32087226
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and selective human monoamine oxidase B inhibition of heterocyclic hybrids based on hydrazine and thiazole scaffolds.
Carradori S; D'Ascenzio M; De Monte C; Secci D; Yáñez M
Arch Pharm (Weinheim); 2013 Jan; 346(1):17-22. PubMed ID: 23065686
[TBL] [Abstract][Full Text] [Related]
24. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
Baek SC; Kang MG; Park JE; Lee JP; Lee H; Ryu HW; Park CM; Park D; Cho ML; Oh SR; Kim H
Bioorg Med Chem Lett; 2019 Mar; 29(6):839-843. PubMed ID: 30686752
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
Chimenti F; Secci D; Bolasco A; Chimenti P; Bizzarri B; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 Apr; 52(7):1935-42. PubMed ID: 19267475
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; Korkut B; Atlı Ö; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2018 Jan; 144():68-81. PubMed ID: 29248751
[TBL] [Abstract][Full Text] [Related]
27. Potent and Selective Monoamine Oxidase-B Inhibitory Activity: Fluoro- vs. Trifluoromethyl-4-hydroxylated Chalcone Derivatives.
Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Mathew S; Haridas A; Jayaprakash V
Chem Biodivers; 2016 Aug; 13(8):1046-52. PubMed ID: 27402375
[TBL] [Abstract][Full Text] [Related]
28. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
29. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
[TBL] [Abstract][Full Text] [Related]
30. Discovery of highly selective and potent monoamine oxidase B inhibitors: Contribution of additional phenyl rings introduced into 2-aryl-1,3,4-oxadiazin-5(6H)-one.
Lee J; Lee Y; Park SJ; Lee J; Kim YS; Suh YG; Lee J
Eur J Med Chem; 2017 Apr; 130():365-378. PubMed ID: 28273563
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, Biochemistry, and Computational Studies of Brominated Thienyl Chalcones: A New Class of Reversible MAO-B Inhibitors.
Mathew B; Haridas A; Uçar G; Baysal I; Joy M; Mathew GE; Lakshmanan B; Jayaprakash V
ChemMedChem; 2016 Jun; 11(11):1161-71. PubMed ID: 27159243
[TBL] [Abstract][Full Text] [Related]
32. Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition.
Matos MJ; Vilar S; García-Morales V; Tatonetti NP; Uriarte E; Santana L; Viña D
ChemMedChem; 2014 Jul; 9(7):1488-500. PubMed ID: 24715707
[TBL] [Abstract][Full Text] [Related]
33. Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.
Matos MJ; Rodríguez-Enríquez F; Vilar S; Santana L; Uriarte E; Hripcsak G; Estrada M; Rodríguez-Franco MI; Viña D
Bioorg Med Chem Lett; 2015 Feb; 25(3):642-8. PubMed ID: 25532905
[TBL] [Abstract][Full Text] [Related]
34. Monoamine Oxidase Inhibitory Activity of Ferulic Acid Amides: Curcumin-Based Design and Synthesis.
Badavath VN; Baysal İ; Uçar G; Mondal SK; Sinha BN; Jayaprakash V
Arch Pharm (Weinheim); 2016 Jan; 349(1):9-19. PubMed ID: 26592858
[TBL] [Abstract][Full Text] [Related]
35. Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies.
Mathew B; Mathew GE; Uçar G; Baysal I; Suresh J; Vilapurathu JK; Prakasan A; Suresh JK; Thomas A
Bioorg Chem; 2015 Oct; 62():22-9. PubMed ID: 26189013
[TBL] [Abstract][Full Text] [Related]
36. A rational approach to elucidate human monoamine oxidase molecular selectivity.
Mangiatordi GF; Alberga D; Pisani L; Gadaleta D; Trisciuzzi D; Farina R; Carotti A; Lattanzi G; Catto M; Nicolotti O
Eur J Pharm Sci; 2017 Apr; 101():90-99. PubMed ID: 28188911
[TBL] [Abstract][Full Text] [Related]
37. Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A.
Baek SC; Park MH; Ryu HW; Lee JP; Kang MG; Park D; Park CM; Oh SR; Kim H
Bioorg Chem; 2019 Mar; 83():317-325. PubMed ID: 30396116
[TBL] [Abstract][Full Text] [Related]
38. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.
Tong X; Chen R; Zhang TT; Han Y; Tang WJ; Liu XH
Bioorg Med Chem; 2015 Feb; 23(3):515-25. PubMed ID: 25541201
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Yáñez M; Vitali A; Ortuso F; Alcaro S
Bioorg Med Chem Lett; 2010 Nov; 20(22):6479-82. PubMed ID: 20934874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
